These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 8607112)
21. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes. Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392 [TBL] [Abstract][Full Text] [Related]
22. [Increased fibrinolytic activity during surgery with cardiopulmonary bypass]. Gando S; Tedo I; Goda Y; Kubota M Masui; 1990 Jun; 39(6):751-6. PubMed ID: 2388394 [TBL] [Abstract][Full Text] [Related]
23. Mild hyperhomocysteinemia is associated with a decreased fibrinolytic activity in patients after ST-elevation myocardial infarction. Speidl WS; Nikfardjam M; Niessner A; Zeiner A; Jordanova N; Zorn G; Maurer G; Schreiber W; Wojta J; Huber K Thromb Res; 2007; 119(3):331-6. PubMed ID: 16616324 [TBL] [Abstract][Full Text] [Related]
24. Changes in hemostasis during pediatric heart surgery: impact of a biocompatible heparin-coated perfusion system. Jensen E; Andréasson S; Bengtsson A; Berggren H; Ekroth R; Larsson LE; Ouchterlony J Ann Thorac Surg; 2004 Mar; 77(3):962-7. PubMed ID: 14992907 [TBL] [Abstract][Full Text] [Related]
25. Changes in the fibrinolytic components of cultured human umbilical vein endothelial cells induced by endotoxin, tumor necrosis factor-alpha and interleukin-1alpha. Orbe J; Chordá C; Montes R; Páramo JA Haematologica; 1999 Apr; 84(4):306-11. PubMed ID: 10190943 [TBL] [Abstract][Full Text] [Related]
26. Effect of blood passage through the pulmonary circulation on fibrinolytic parameters. Kloboves-Prevodnik V; Sabovic M; Keber D Heart Vessels; 2004 Jan; 19(1):33-7. PubMed ID: 14685753 [TBL] [Abstract][Full Text] [Related]
27. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions. Alemán C; Alegre J; Monasterio J; Segura RM; Armadans L; Anglés A; Varela E; Ruiz E; Fernández de Sevilla T Clin Sci (Lond); 2003 Nov; 105(5):601-7. PubMed ID: 12826021 [TBL] [Abstract][Full Text] [Related]
28. Transmyocardial fibrinolytic activity in patients with unstable angina pectoris. Daniel WC; Meidell RS; Hillis LD; Lange RA Coron Artery Dis; 1996 Jan; 7(1):45-9. PubMed ID: 8773432 [TBL] [Abstract][Full Text] [Related]
30. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism]. Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355 [TBL] [Abstract][Full Text] [Related]
31. Fibrinolytic parameters in patients undergoing total hip replacement: relationship with the development of asymptomatic deep vein thrombosis and diagnostic usefulness of venous occlusion. Trotti R; Siragusa S; Rondanelli M; Chezzi L; Citterio A; Melzi d'Eril GV; Piovella F Haematologica; 1997; 82(2):178-81. PubMed ID: 9175322 [TBL] [Abstract][Full Text] [Related]
32. Effect of fluvastatin and valsartan, alone and in combination, on postprandial vascular inflammation and fibrinolytic activity in patients with essential hypertension. Liu L; Zhao SP; Zhou HN; Li QZ; Li JX J Cardiovasc Pharmacol; 2007 Jul; 50(1):50-5. PubMed ID: 17666915 [TBL] [Abstract][Full Text] [Related]
33. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis. Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167 [TBL] [Abstract][Full Text] [Related]
34. Glucagon as a determinant of fibrinolytic activity in men with different stages of glucose tolerance: impact of glucagon on fibrinolysis. Henkel E; Gallo S; Siegert G; Koehler C; Hanefeld M Blood Coagul Fibrinolysis; 2007 Jun; 18(4):327-34. PubMed ID: 17473573 [TBL] [Abstract][Full Text] [Related]
35. Does off-pump coronary artery bypass surgery reduce secretion of plasminogen activator inhibitor-1? Ozkara C; Guler N; Batyraliev T; Okut H; Agirbasli M Int J Clin Pract; 2007 May; 61(5):763-7. PubMed ID: 17343662 [TBL] [Abstract][Full Text] [Related]
36. The fibrinolytic system in chronic renal failure. Lottermoser K; Petras S; Pöge U; Fimmers R; Hertfelder HJ; Schiermeyer B; Vetter H; Düsing R Eur J Med Res; 2001 Sep; 6(9):372-6. PubMed ID: 11591527 [TBL] [Abstract][Full Text] [Related]
37. Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia. Sebestjen M; Zegura B; Guzic-Salobir B; Keber I Wien Klin Wochenschr; 2001 Feb; 113(3-4):113-8. PubMed ID: 11253736 [TBL] [Abstract][Full Text] [Related]
38. [Tissue plasminogen activator and plasminogen activator inhibitor in aqueous humor]. Giedrojć J; Stankiewicz A; Walkowiak M; Galar M; Bielawiec M Klin Oczna; 1996; 98(4):283-5. PubMed ID: 9463119 [TBL] [Abstract][Full Text] [Related]
39. Relationship of fibrinolysis and platelet function to bleeding after cardiopulmonary bypass. Ray MJ; Marsh NA; Hawson GA Blood Coagul Fibrinolysis; 1994 Oct; 5(5):679-85. PubMed ID: 7865673 [TBL] [Abstract][Full Text] [Related]
40. Systematic elucidation of effects of tranexamic acid on fibrinolysis and bleeding during and after cardiopulmonary bypass surgery. Kojima T; Gando S; Morimoto Y; Mashio H; Goda Y; Kawahigashi H; Kemmotsu O Thromb Res; 2001 Dec; 104(5):301-7. PubMed ID: 11738071 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]